etoposide has been researched along with Weight Loss in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozarek, RA; Masood, M; Siddique, A | 1 |
| Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP | 1 |
| Dul, C; Khan, U | 1 |
| Asha, HS; Chacko, RT; Eapen, A; Fleming, JJ; Hepzibah, J; Kapoor, N; Ramakrishna, B; Somasundaram, N; Thomas, N | 1 |
| Chamberlain, MC | 1 |
| Debelenko, L; Granowetter, L; Hensle, TW; Lam, JS; Tennenbaum, SY | 1 |
| Bowman, CA; Fetherstonhaugh, EM; Gelmon, K; Karsai, H; Knowling, MA; Mclaughlin, MJ; Murray, N; Osoba, D; Page, R; Shah, A | 1 |
| Edison, M; Gazdar, AF; Ihde, DC; Kramer, BS; Lesar, M; Linnoila, RI; Mulshine, JL; Phares, JC; Phelps, RM; Steinberg, SM | 1 |
| Andras, EJ; Asbell, SO; Byhardt, RW; Cox, JD; Emami, B; Komaki, R; Lee, JS; Rotman, M; Scott, C; Urtasun, RC | 1 |
| Kasai, H; Maekawa, R; Sugita, K; Takeda, Y; Uchida, N; Yoshioka, T | 1 |
5 trial(s) available for etoposide and Weight Loss
| Article | Year |
|---|---|
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss | 2015 |
Salvage chemotherapy for recurrent spinal cord ependymona.
Topics: Administration, Oral; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Spinal Cord Neoplasms; Thrombocytopenia; Treatment Outcome; Weight Loss | 2002 |
Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Megestrol; Middle Aged; Mitomycins; Vincristine; Weight Loss | 1994 |
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Remission Induction; Survival Rate; Thrombocytopenia; Weight Loss | 1994 |
Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Carcinoma, Non-Small-Cell Lung; Cause of Death; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Injections, Intravenous; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Radiotherapy; Radiotherapy Dosage; Remission Induction; Sex Factors; Survival Rate; Treatment Outcome; Vinblastine; Weight Loss | 1997 |
5 other study(ies) available for etoposide and Weight Loss
| Article | Year |
|---|---|
Adult Hemophagocytic Lymphohistiocytosis Mimicking Acute Viral Hepatitis.
Topics: Adult; Anorexia; Anti-Inflammatory Agents; Bone Marrow; Dexamethasone; Diagnosis, Differential; Etoposide; Ferritins; Hepatitis, Viral, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Muscle Weakness; Treatment Outcome; Weight Loss | 2023 |
Circulating lymphoma cells of double-hit lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Gastrointestinal Hemorrhage; Humans; Lymphoma, B-Cell; Male; Pancytopenia; Prednisone; Treatment Outcome; Vincristine; Weight Loss | 2016 |
An unusual cause for weight loss and diabetes.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diabetes Mellitus; Etoposide; Glucagonoma; Humans; Liver Neoplasms; Male; Octreotide; Pancreatic Neoplasms; Weight Loss | 2011 |
Organ-confined primitive neuroectodermal tumor arising from the kidney.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Nephrectomy; Neuroectodermal Tumors, Primitive; Remission Induction; Vincristine; Weight Loss | 2003 |
[Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Synergism; Etoposide; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organoplatinum Compounds; Weight Loss | 1998 |